Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by OptimizeRx Corporation

< Previous 1 2 Next >
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX WMT
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
From OptimizeRx Corporation
Via GlobeNewswire
Tickers AWH OPRX
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Third Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Expands AI Powered Omnichannel Platform
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Second Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports First Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Authorizes $15 Million Share Repurchase Program
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.